Options
Diagnostic accuracy of the BioFire® FilmArray® pneumonia panel in COVID-19 patients with ventilator-associated pneumonia
Journal
BMC Infectious Diseases
ISSN
1471-2334
Date Issued
2023
Author(s)
Cojuc-Konigsberg, Gabriel
Moscona-Nissan, Alberto
Guijosa, Alberto
Mireles Dávalos, Christian D.
Jiménez Martínez, María E.
Mújica Sánchez, Mario A.
Hernández Huizar, Víctor F.
Durán Barrón, Martha A.
Villarreal Gómez, Karen
Andrade-Galindo, Regina
Ordóñez-Oviedo, Montserrat
Deloya Brito, Grecia
Becerril Vargas, Eduardo
Type
Resource Types::text::journal::journal article
Abstract
Background: Ventilator-Associated pneumonia (VAP) is one of the leading causes of morbidity and mortality in critically ill COVID-19 patients in lower-and-middle-income settings, where timely access to emergency care and accurate diagnostic testing is not widely available. Therefore, rapid microbiological diagnosis is essential to improve effective therapy delivery to affected individuals, preventing adverse outcomes and reducing antimicrobial resistance. Methods: We conducted a cross-sectional study of patients with suspected VAP and COVID-19, evaluating the diagnostic performance of the BioFire® FilmArray® Pneumonia Panel (FA-PP). Respiratory secretion samples underwent standard microbiological culture and FA-PP assays, and the results were compared. ©BMC Infectious Diseases